Delivery Order SPE2DB20D2104-SPE2DB24FV74H
- Not listed
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,054.96 Firm Fixed Price Delivery Order contract is for the supply of 120 count bottles of Abiraterone Acetate 250 mg tablets, a medication used in the treatment of prostate cancer. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,197.04 Firm Fixed Price delivery order is for the supply of 4,557,943,655 tablets of Abiraterone Acetate 250 mg, a medication used to treat prostate cancer. The contract has an ultimate completion date of August 1, 2022 and was awarded on July 29, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,968.55 Firm Fixed Price delivery order contract is for the supply of Abiraterone Acetate 500 mg tablets, a medication used in the treatment of prostate cancer. The contract has an ultimate completion date of January 13, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
- This federal contract award, valued at $1,165.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,998,854 tablets of Abiraterone Acetate 250 mg, a medication used in the treatment of prostate cancer. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 23, 2025. This contract is not set aside and is open to full and open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,491.64 firm fixed-price delivery order is for the supply of 4,564,965,578 units of Abiraterone Acetate 500 mg tablets, with a completion date of June 24, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This federal contract award, valued at $2,275.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of 250 mg Abiraterone Acetate, a medication used in the treatment of prostate cancer. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 21, 2023. It is not designated as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,182.10 firm fixed-price delivery order contract is for the supply of 4,565,950,374 units of abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of September 27, 2024. This delivery order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,822.78 firm fixed price delivery order is for the supply of 4565133468 Abiraterone Acetate 250 mg tablets. The contract has a ceiling value of $1,822.78 and a completion date of July 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,070.65 firm fixed-price delivery order is for 4,566,814,766 units of Abiraterone Acetate 250 mg tablets, a medication used in the treatment of certain types of cancer. The contract has an ultimate completion date of January 2, 2025. This award appears to be part of a larger Indefinite Delivery...
- This federal contract award, valued at $10,423.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Abiraterone Acetate 500 mg tablets, a medication used to treat prostate cancer. This contract is not designated as a set-aside, indicating open competition. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FV74HDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,851.38 firm-fixed-price delivery order is for the supply of 4,565,481,171 tablets of Abiraterone Acetate 250 mg, a medication used for the treatment of prostate cancer. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award is a delivery order under that IDC, demonstrating the company's extensive capabilities in fulfilling the medical needs of the U.S. military and federal healthcare institutions. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/16/24 |